US$ 26.11
is semaglutide wegovy Ozempic vs. vs. Mounjaro: What's the Difference? More than 170,000 people in
Description
The Rosenstock Phase 2 in type 2 diabetes assigned 281 adults T2D, BMI 25 to retatrutide across multiple dose tiers, an active GLP-1 mono-agonist comparator, or placebo

The two drugs belong to different classes of drugs and have some differences in their mechanisms of action, dosing, and efficacy

Semaglutide is the established GLP-1 receptor agonist with three FDA approvals and the most comprehensive clinical evidence base in its class

Semaglutide addresses insulin resistance directly, often restoring hormonal balance in PCOS patients